Generelt lignede emtricitabins farmakokinetik hos HBV- inficerede patienter den hos raske probander og hos HIV- inficerede patienter.
In general, emtricitabine pharmacokinetics in HBV infected subjects were similar to those in healthy subjects and in HIV infected subjects.